BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/6/2021 2:28:34 PM | Browse: 130 | Download: 204
Publication Name World Journal of Clinical Cases
Manuscript ID 64082
Country/Territory Poland
Category Oncology
Manuscript Type Case Report
Article Title Low symptomatic COVID-19 in the elderly patient with follicular lymphoma treated with rituximab-based immunotherapy: A case report
Manuscript Source Unsolicited Manuscript
All Author List Stanisław Łącki, Kinga Wyżgolik, Michał Nicze, Sylwia Georgiew-Nadziakiewicz, Jerzy Chudek and Kamil Wdowiak
Funding Agency and Grant Number
Corresponding Author Stanisław Łącki, N/A, N/A, Department of Internal Diseases and Oncological Chemotherapy, Medical University of Silesia, Reymonta 8, Katowice 40-027, Silesian Voivodeship, Poland. s.lacki@outlook.com
Key Words COVID-19; SARS-Co-V-2; Follicular lymphoma; Rituximab; Case report
Core Tip Follicular lymphoma (FL) is an indolent lymphoma requiring immunochemotherapy with rituximab. This anti-CD20 monoclonal antibody causes rapid and prolonged depletion of both malignant and normal B-cells, resulting in a significantly increased risk of infectious complications, including the novel coronavirus (severe acute respiratory syndrome coronavirus 2) infections (coronavirus disease 2019, COVID-19). We present here the first case of a mildly manifested COVID-19 in the elderly patient during ongoing FL treatment, without significant deterioration after rituximab administration. This case highlights that rituximab-based therapy may have no evident negative effect on the clinical course of COVID-19 in the patients with FL, which may be significant during the current pandemic.
Citation Łącki S, Wyżgolik K, Nicze M, Georgiew-Nadziakiewicz S, Chudek J, Wdowiak K. Low symptomatic COVID-19 in the elderly patient with follicular lymphoma treated with rituximab-based immunotherapy: A case report. World J Clin Cases 2021; 9(18): 4859-4865
Received
2021-02-08 12:13
Peer-Review Started
2021-02-08 12:22
To Make the First Decision
Return for Revision
2021-04-04 17:25
Revised
2021-04-13 09:41
Second Decision
2021-05-06 14:07
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-05-06 14:28
Articles in Press
2021-05-06 14:28
Publication Fee Transferred
Edit the Manuscript by Language Editor
2021-05-09 22:16
Typeset the Manuscript
2021-05-29 04:41
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com